FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes - FDA Press Releases

FDA has authorized 23andMe to market a consumer test that reports only 3 out of more than 1,000 known mutations in BRCA genes

from Food and Drug Administration--Press Releases http://ift.tt/2D56J3a
via IFTTT